UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Asıl Yazarlar: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Elsevier
2017
|
Benzer Materyaller
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
Yazar:: Hanna, G, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Stereotactic body radiotherapy for liver metastases.
Yazar:: Aitken, K, ve diğerleri
Baskı/Yayın Bilgisi: (2015) -
Stereotactic body radiotherapy for oligometastases.
Yazar:: Tree, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
Yazar:: Khoo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
Yazar:: Khoo, V, ve diğerleri
Baskı/Yayın Bilgisi: (2017)